123 related articles for article (PubMed ID: 6276143)
21. Calcium hopantenate, a GABA agonist, induces elevation of plasma beta-endorphin-like immunoreactivity levels in rats.
Mitsuma T; Sun DH; Nogimori T; Chaya M; Ohtake K; Hirooka Y
Exp Clin Endocrinol; 1987 Apr; 89(2):181-7. PubMed ID: 2956119
[TBL] [Abstract][Full Text] [Related]
22. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
23. Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat.
Locatelli V; Petraglia F; Penalva A; Panerai AE
Life Sci; 1983 Oct; 33(17):1711-7. PubMed ID: 6314082
[TBL] [Abstract][Full Text] [Related]
24. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
Autelitano DJ; Clements JA; Nikolaidis I; Canny BJ; Funder JW
Endocrinology; 1987 Nov; 121(5):1689-96. PubMed ID: 2959468
[TBL] [Abstract][Full Text] [Related]
25. Inhibition by lithium of dopamine receptors in rat prolactin release.
Tanimoto K; Maeda K; Chihara K
Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid inhibition of immunoreactive beta-endorphin release from the anterior lobe of the rat pituitary: in vitro and in vivo studies.
Mueller GP; Pettibone DJ; Farah JM; Sapun-Malcolm D
Proc Soc Exp Biol Med; 1985 Jul; 179(3):338-47. PubMed ID: 3159023
[TBL] [Abstract][Full Text] [Related]
27. The biphasic regulation of prolactin secretion by dopamine agonist-antagonists.
MacLeod RM; Lamberts SW
Endocrinology; 1978 Jul; 103(1):200-3. PubMed ID: 744072
[TBL] [Abstract][Full Text] [Related]
28. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
Demarest KT; Moore KE; Riegle GD
Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
[TBL] [Abstract][Full Text] [Related]
29. Beta-endorphin secretion in rams related to season and photoperiod.
Ebling FJ; Lincoln GA
Endocrinology; 1987 Feb; 120(2):809-18. PubMed ID: 2948817
[TBL] [Abstract][Full Text] [Related]
30. Identification and secretion of gamma-endorphin and beta-endorphin-like peptides from the neurointermediate pituitary of the rat.
Dorsa DM; Keith LD
Prog Clin Biol Res; 1985; 192():285-92. PubMed ID: 2417252
[TBL] [Abstract][Full Text] [Related]
31. Chronic activation of dopamine receptors in the female infantile rat: effect on hypophyseal hormones and on the onset of puberty.
de Mengido IM; Becú-Villalobos D; Díaz G; Libertun C
Endocrinology; 1989 Feb; 124(2):746-53. PubMed ID: 2492218
[TBL] [Abstract][Full Text] [Related]
32. Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain.
Sweep CG; Boersma CJ; Wiegant VM
Neuropharmacology; 1990 Jan; 29(1):61-8. PubMed ID: 1689470
[TBL] [Abstract][Full Text] [Related]
33. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin-releasing hormone reduces the plasma levels of beta-endorphin-like immunoreactivity in rats.
Mitsuma T; Nogimori T; Sun DH; Chaya M
Exp Clin Endocrinol; 1987 Mar; 89(1):55-60. PubMed ID: 2954835
[TBL] [Abstract][Full Text] [Related]
35. Long-term haloperidol treatment elevates beta-endorphin levels in the intermediate pituitary but not in rat brain.
Millington WR; Maiewski S; O'Donohue TL; Mueller GP
Neuropeptides; 1985 Jul; 6(4):365-72. PubMed ID: 2931616
[TBL] [Abstract][Full Text] [Related]
36. Haloperidol increases plasma beta endorphin-like immunoreactivity and cortisol in normal human males.
Murburg MM; Paly D; Wilkinson CW; Veith RC; Malas KL; Dorsa DM
Life Sci; 1986 Jul; 39(4):373-81. PubMed ID: 2942747
[TBL] [Abstract][Full Text] [Related]
37. Anesthesia and stimulation of pituitary beta-endorphin release in rats.
Maiewski S; Muldoon S; Mueller GP
Proc Soc Exp Biol Med; 1984 Jul; 176(3):268-75. PubMed ID: 6328533
[TBL] [Abstract][Full Text] [Related]
38. Dopaminergic agents differentially alter beta-endorphin processing patterns in the rat pituitary neurointermediate lobe.
Autelitano DJ; Smith AI; Lolait SJ; Funder JW
Neurosci Lett; 1985 Aug; 59(1):141-6. PubMed ID: 2931629
[TBL] [Abstract][Full Text] [Related]
39. Coordinate regulation of peptide acetyltransferase activity and proopiomelanocortin gene expression in the intermediate lobe of the rat pituitary.
Millington WR; O'Donohue TL; Chappell MC; Roberts JL; Mueller GP
Endocrinology; 1986 May; 118(5):2024-33. PubMed ID: 2938933
[TBL] [Abstract][Full Text] [Related]
40. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
Hagino Y; Okuwa M; Moroji T
Neuropeptides; 1991 Jan; 18(1):1-14. PubMed ID: 2046884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
